partnering human iron


sales & marketing


Pharmacosmos works closely and actively with our partners around the world for the marketing of our IV iron products. We believe that the combination of our partners' local expertise within Sales, Marketing and Market Access combined with Pharmacosmos' deep knowledge of the international market for IV iron and the treatment of Iron Deficiency, is the foundation for a successful business and a solid long-term business relationship. Key words in the relationships with our partners are dedication, professionalism, long term relationships and mutual respect and understanding.

Apart from our partners being professional and competent within the marketing of ethical pharmaceutical products, we ask our partners to be dedicated to making Monofer a success in a close cooperation with Pharmacosmos, which entail that sufficient dedicated resources are assigned to the Monofer business. Furthermore, the partner shoul have existing business in some of the relevant segments, typically gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.

Out-licensing


Pharmacosmos are looking for partners for IV Iron in:

  • US (Ph 3): Commercial partner. The US IV iron market alone is worth ~$636M (2014) and is expected to reach ~$1B by ~2020 and ~$1.6B by 2030. The main growth drivers are increased use of IV iron outside dialysis and transition to high-dose premium products
  • France, Italy, Switzerland: Commercial partner
  • Middle East and Northern Africa: Commercial partner including registration
  • Latin America: Commercial partner including registration

To learn more, please contact Michael Ryde at info@pharmacosmos.com

 

In-licensing


We promote our products through own sales and marketing organisations in the Nordic countries and UK/Ireland and we are looking to in-license complementary specialty care products within gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.

Our focus is on complex and innovative products with IP protection and a scientific content, in registration phase or having been on the market for a number of years.

To learn more, please contact Michael Ryde at info@pharmacosmos.com

 

collaboration with resarchers & clinicians


We collaborate with leading medical experts in driving research to uncover new clinical insights of iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans. We are actively seeking opportunities to collaborate on investigator sponsored studies.

To learn more, please contact Lars L. Thomsen at info@pharmacosmos.com

Veterinary iron


Partnering opportunities - Veterinary Iron

Carbohydrates


Partnering opportunities - Carbohydrates